![](/img/cover-not-exists.png)
Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model
Milena Veselinovic, C. Preston Neff, Leila R. Mulder, Ramesh AkkinaVolume:
432
Year:
2012
Language:
english
DOI:
10.1016/j.virol.2012.06.025
File:
PDF, 296 KB
english, 2012